Safety and effectiveness of Janus kinase inhibitors in the management of inflammatory bowel disease following liver transplantation.

As the largest case series to-date, these data indicate that combining JAK inhibition with transplant anti-rejection medication may be a safe and clinically effective method of treating IBD in patients with prior biologic failure.